{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:41:25Z","timestamp":1793900485838,"version":"4.8.0"},"reference-count":36,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Elevated levels of serum ferritin, a marker of hepatic iron overload and inflammation, may be associated with metabolic dysfunction\u2010associated steatotic liver disease (MASLD) and hepatic fibrosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To determine the prevalence of MASLD and significant hepatic fibrosis among patients with type 2 diabetes mellitus (T2DM) and hyperferritinaemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a cross\u2010sectional analysis of a prospective cohort of 523 adults (64% female) aged 50\u201380 with T2DM and without a diagnosis of haemochromatosis. MASLD and significant fibrosis were defined as magnetic resonance imaging\u2010proton density fat fraction (MRI\u2010PDFF)\u2009\u2265\u20095% and magnetic resonance elastography (MRE)\u2009\u2265\u20093.0\u2009kPa, respectively. Hyperferritinaemia was defined as serum ferritin\u2009\u2265\u2009200\u2009ng\/mL in females or\u2009\u2265\u2009300\u2009ng\/mL in males. The <jats:italic>primary objective<\/jats:italic> was to determine the prevalence of MASLD and significant fibrosis in hyperferritinaemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean age and body mass index were 64.1 (\u00b18.1) years and 31.5 (\u00b15.9) kg\/m<jats:sup>2<\/jats:sup>, respectively. The overall prevalence of hyperferritinaemia was 20.5% (<jats:italic>n<\/jats:italic>\u2009=\u2009107). The prevalence of MASLD (78.5% vs. 62.1%, <jats:italic>p<\/jats:italic>\u2009=\u20090.001) and significant fibrosis (35.5% vs. 22.1%, <jats:italic>p<\/jats:italic>\u2009=\u20090.002) were higher in participants with hyperferritinaemia than those without. Hyperferritinaemia remained an independent predictor of MASLD (OR 2.01; 95% CI 1.19\u20133.39; <jats:italic>p<\/jats:italic>\u2009=\u20090.009) and significant fibrosis (OR 2.33; CI 1.43\u20133.77; <jats:italic>p<\/jats:italic>\u2009=\u20090.001), even after adjustment for age, sex, obesity and insulin use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Approximately 80% of people with hyperferritinaemia and T2DM have MASLD, and more than a third have significant hepatic fibrosis. Hyperferritinaemia may be a useful biomarker for MASLD and significant fibrosis in people with T2DM.<\/jats:p><\/jats:sec>","DOI":"10.1111\/apt.18377","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T14:49:52Z","timestamp":1730818192000},"page":"456-464","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["A Prospective Study on the Prevalence of <scp>MASLD<\/scp> in Patients With Type 2 Diabetes and Hyperferritinaemia"],"prefix":"10.1111","volume":"61","author":[{"given":"Maral","family":"Amangurbanova","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, MASLD Research Center University of California at San Diego  La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5165-5061","authenticated-orcid":false,"given":"Daniel Q.","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, MASLD Research Center University of California at San Diego  La Jolla California USA"},{"name":"Department of Medicine, Yong Loo Lin School of Medicine National University of Singapore  Singapore Singapore"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine National University Health System  Singapore Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Noureddin","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, MASLD Research Center University of California at San Diego  La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaleb","family":"Tesfai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, MASLD Research Center University of California at San Diego  La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richelle","family":"Bettencourt","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, MASLD Research Center University of California at San Diego  La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harris","family":"Siddiqi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, MASLD Research Center University of California at San Diego  La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarlett J.","family":"Lopez","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, MASLD Research Center University of California at San Diego  La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Cervantes","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, MASLD Research Center University of California at San Diego  La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert","family":"Madamba","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, MASLD Research Center University of California at San Diego  La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-9991","authenticated-orcid":false,"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, MASLD Research Center University of California at San Diego  La Jolla California USA"},{"name":"Division of Epidemiology, Department of Family Medicine and Public Health University of California at San Diego  San Diego California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330110"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1091978"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.147"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.11.010"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0613-4"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-018-9892-8"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24706"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.05.043"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14096"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i2.177"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12343"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05153-0"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02083"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101235"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.02.019"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.05.008"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.09.018"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04052.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-023-00807-6"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2010.01.003"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13513"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S002"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13405"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2007.00403.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.1982.43.1157"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"e_1_2_8_29_1","unstructured":"\u201cSerum Ferritin Level Microalbuminuria and Non\u2010Alcoholic Fatty Liver Disease in Type 2 Diabetic Patients \u2010 ScienceDirect.\u201dhttps:\/\/www.sciencedirect.com\/science\/article\/pii\/S1871402119303005."},{"key":"e_1_2_8_30_1","first-page":"1","article-title":"Serum Iron Is Closely Associated With Metabolic Dysfunction\u2010Associated Fatty Liver Disease in Type 2 Diabetes: A Real\u2010World Study","volume":"13","author":"Wang J.\u2010W.","year":"2022","journal-title":"Frontiers in Endocrinology"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0367"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15649"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15747"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02397-7"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.03.017"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.8.2348"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1159\/000229507"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.18377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T09:42:50Z","timestamp":1736329370000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.18377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1111\/apt.18377"],"URL":"https:\/\/doi.org\/10.1111\/apt.18377","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"2024-08-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}